Literature DB >> 30721378

Premenopausal cardiovascular disease and age at natural menopause: a pooled analysis of over 170,000 women.

Dongshan Zhu1, Hsin-Fang Chung2, Nirmala Pandeya2,3, Annette J Dobson2, Rebecca Hardy4, Diana Kuh4, Eric J Brunner5, Fiona Bruinsma6, Graham G Giles6,7, Panayotes Demakakos5, Jung Su Lee8, Hideki Mizunuma9, Kunihiko Hayashi10, Hans-Olov Adami11,12, Elisabete Weiderpass11,13,14,15, Gita D Mishra2.   

Abstract

Early menopause is associated with an increased risk of subsequent cardiovascular disease (CVD). Few studies have investigated the converse. We examined whether premenopausal CVD events are associated with early age at menopause. We pooled the individual data of 177,131 women from nine studies. We used multinomial logistic regression models to estimate multivariable relative risk ratios (RRR) and 95% confidence intervals (CI) for the associations between age at onset of premenopausal CVD events-including coronary heart disease (CHD) and stroke-and age at natural menopause. Altogether 1561 (0.9%) premenopausal participants reported CVD events (including 1130 CHD and 469 stroke) at a mean age of 41.3 years. Compared with women without any premenopausal CVD events, women who experienced a first CVD event before age 35 years had a twofold risk of menopause before age 45 years (early menopause); adjusted RRR (95% CI) of 1.92 (1.17, 3.14) for any CVD, 1.86 (1.01, 3.43) for CHD and 2.17 (1.43, 3.30) for stroke. Women who experienced a first premenopausal CVD event after age 40 years underwent a natural menopause at the expected age (around 51 years). These associations were robust to adjustment for smoking status, BMI, educational level, race/ethnicity, age at menarche, parity, hypertension and family history of CVD. For premenopausal women, a first CVD event before age 35 years is associated with a doubling of the risk of an early menopause, while a first CVD event occurred after 35 years indicates a normal menopause at around 51 years. Shared genetic and environmental factors (such as smoking), as well as compromised vasculature following CVD events, may contribute to this outcome.

Entities:  

Keywords:  Age at menopause; Cardiovascular disease; Pooled analysis; Premenopausal

Mesh:

Year:  2019        PMID: 30721378     DOI: 10.1007/s10654-019-00490-w

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  45 in total

Review 1.  Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis.

Authors:  Femke Atsma; Marie-Louise E L Bartelink; Diederick E Grobbee; Yvonne T van der Schouw
Journal:  Menopause       Date:  2006 Mar-Apr       Impact factor: 2.953

2.  Menopause and cardiovascular risk cause or consequence?

Authors:  Vera Bittner
Journal:  J Am Coll Cardiol       Date:  2006-04-24       Impact factor: 24.094

3.  Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study.

Authors:  J P Strong; G T Malcom; C A McMahan; R E Tracy; W P Newman; E E Herderick; J F Cornhill
Journal:  JAMA       Date:  1999-02-24       Impact factor: 56.272

4.  High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: evidence from intravascular ultrasound.

Authors:  E M Tuzcu; S R Kapadia; E Tutar; K M Ziada; R E Hobbs; P M McCarthy; J B Young; S E Nissen
Journal:  Circulation       Date:  2001-06-05       Impact factor: 29.690

5.  Heart disease risk determines menopausal age rather than the reverse.

Authors:  Helen S Kok; Kristel M van Asselt; Yvonne T van der Schouw; Ingeborg van der Tweel; Petra H M Peeters; Peter W F Wilson; Peter L Pearson; Diederick E Grobbee
Journal:  J Am Coll Cardiol       Date:  2006-04-24       Impact factor: 24.094

6.  Changes in cardiovascular risk factors during the perimenopause and postmenopause and carotid artery atherosclerosis in healthy women.

Authors:  K A Matthews; L H Kuller; K Sutton-Tyrrell; Y F Chang
Journal:  Stroke       Date:  2001-05       Impact factor: 7.914

7.  Polymorphisms associated with thrombophilia and vascular homeostasis and the timing of menarche and menopause in 728 white women.

Authors:  Clemens B Tempfer; Eva-Katrin Riener; Christoph Keck; Christoph Grimm; Georg Heinze; Johannes C Huber; Gerald Gitsch; Lukas A Hefler
Journal:  Menopause       Date:  2005 May-Jun       Impact factor: 2.953

8.  Long-term follow-up of coronary artery disease presenting in young adults.

Authors:  Jason H Cole; Joseph I Miller; Laurence S Sperling; William S Weintraub
Journal:  J Am Coll Cardiol       Date:  2003-02-19       Impact factor: 24.094

9.  Factor V Leiden mutation accelerates the onset of natural menopause.

Authors:  Kristel M van Asselt; Helen S Kok; Petra H M Peeters; Mark Roest; Peter L Pearson; Egbert R te Velde; Diederick E Grobbee; Yvonne T van der Schouw
Journal:  Menopause       Date:  2003 Sep-Oct       Impact factor: 2.953

10.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors:  Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272

View more
  11 in total

1.  Idiopathic early ovarian aging: is there a relation with premenopausal accelerated biological aging in young women with diminished response to ART?

Authors:  Mette W Christensen; David L Keefe; Fang Wang; Christine S Hansen; Isaac J Chamani; Carolyn Sommer; Mette Nyegaard; Palle D Rohde; Anders L Nielsen; Jonas Bybjerg-Grauholm; Ulrik S Kesmodel; Ulla B Knudsen; Kirstine Kirkegaard; Hans Jakob Ingerslev
Journal:  J Assist Reprod Genet       Date:  2021-10-01       Impact factor: 3.412

2.  Lipid Profile in Patients With Primary Ovarian Insufficiency: A Systematic Review and Meta-Analysis.

Authors:  Ling Huang; Hanfeng Wang; Minglu Shi; Weizheng Kong; Mei Jiang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-10       Impact factor: 6.055

Review 3.  Evidence for Menopause as a Sex-Specific Risk Factor for Glaucoma.

Authors:  Amber Douglass; Michael Dattilo; Andrew J Feola
Journal:  Cell Mol Neurobiol       Date:  2022-01-04       Impact factor: 4.231

4.  Patterns of menstrual cycle length over the menopause transition are associated with subclinical atherosclerosis after menopause.

Authors:  Samar R El Khoudary; Meiyuzhen Qi; Xirun Chen; Karen Matthews; Amanda A Allshouse; Sybil L Crawford; Carol A Derby; Rebecca C Thurston; Rasa Kazlauskaite; Emma Barinas-Mitchell; Nanette Santoro
Journal:  Menopause       Date:  2021-10-11       Impact factor: 3.310

Review 5.  The Role of Sex-Specific Risk Factors in the Risk Assessment of Atherosclerotic Cardiovascular Disease for Primary Prevention in Women.

Authors:  Priya M Freaney; Sadiya S Khan; Donald M Lloyd-Jones; Neil J Stone
Journal:  Curr Atheroscler Rep       Date:  2020-07-16       Impact factor: 5.113

6.  Association of age at diabetes complication diagnosis with age at natural menopause in women with type 1 diabetes: The Pittsburgh Epidemiology of Diabetes Complications (EDC) Study.

Authors:  Yan Yi; Samar R El Khoudary; Jeanine M Buchanich; Rachel G Miller; Debra Rubinstein; Trevor J Orchard; Tina Costacou
Journal:  J Diabetes Complications       Date:  2021-01-02       Impact factor: 2.852

7.  Genetically Determined Reproductive Aging and Coronary Heart Disease: A Bidirectional 2-sample Mendelian Randomization.

Authors:  Veerle Dam; N Charlotte Onland-Moret; Stephen Burgess; Maria-Dolores Chirlaque; Sanne A E Peters; Ewoud Schuit; Kaja Tikk; Elisabete Weiderpass; Clare Oliver-Williams; Angela M Wood; Anne Tjønneland; Christina C Dahm; Kim Overvad; Marie-Christine Boutron-Ruault; Matthias B Schulze; Antonia Trichopoulou; Pietro Ferrari; Giovanna Masala; Vittorio Krogh; Rosario Tumino; Giuseppe Matullo; Salvatore Panico; Jolanda M A Boer; W M Monique Verschuren; Marit Waaseth; Maria José Sánchez Pérez; Pilar Amiano; Liher Imaz; Conchi Moreno-Iribas; Olle Melander; Sophia Harlid; Maria Nordendahl; Patrik Wennberg; Timothy J Key; Elio Riboli; Carmen Santiuste; Rudolf Kaaks; Verena Katzke; Claudia Langenberg; Nicholas J Wareham; Heribert Schunkert; Jeanette Erdmann; Christina Willenborg; Christian Hengstenberg; Marcus E Kleber; Graciela Delgado; Winfried März; Stavroula Kanoni; George Dedoussis; Panos Deloukas; Majid Nikpay; Ruth McPherson; Markus Scholz; Andrej Teren; Adam S Butterworth; Yvonne T van der Schouw
Journal:  J Clin Endocrinol Metab       Date:  2022-06-16       Impact factor: 6.134

8.  The association of age at natural menopause with pre- to postmenopausal changes in left ventricular structure and function: the Coronary Artery Risk Development in Young Adults (CARDIA) study.

Authors:  Duke Appiah; Chike C Nwabuo; Imo A Ebong; Henrique D Vasconcellos; Melissa F Wellons; Cora E Lewis; Joao A Lima; Pamela J Schreiner
Journal:  Menopause       Date:  2022-05-01       Impact factor: 3.310

9.  Objectives, design and main findings until 2020 from the Rotterdam Study.

Authors:  M Arfan Ikram; Guy Brusselle; Mohsen Ghanbari; André Goedegebure; M Kamran Ikram; Maryam Kavousi; Brenda C T Kieboom; Caroline C W Klaver; Robert J de Knegt; Annemarie I Luik; Tamar E C Nijsten; Robin P Peeters; Frank J A van Rooij; Bruno H Stricker; André G Uitterlinden; Meike W Vernooij; Trudy Voortman
Journal:  Eur J Epidemiol       Date:  2020-05-04       Impact factor: 8.082

10.  Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data.

Authors:  Dongshan Zhu; Hsin-Fang Chung; Annette J Dobson; Nirmala Pandeya; Graham G Giles; Fiona Bruinsma; Eric J Brunner; Diana Kuh; Rebecca Hardy; Nancy E Avis; Ellen B Gold; Carol A Derby; Karen A Matthews; Janet E Cade; Darren C Greenwood; Panayotes Demakakos; Daniel E Brown; Lynnette L Sievert; Debra Anderson; Kunihiko Hayashi; Jung Su Lee; Hideki Mizunuma; Therese Tillin; Mette Kildevæld Simonsen; Hans-Olov Adami; Elisabete Weiderpass; Gita D Mishra
Journal:  Lancet Public Health       Date:  2019-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.